Filing Details
- Accession Number:
- 0001354488-15-005296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-23 20:37:17
- Reporting Period:
- 2015-11-20
- Filing Date:
- 2015-11-23
- Accepted Time:
- 2015-11-23 20:37:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569877 | K Andrew Chan | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-20 | 4,036 | $20.46 | 155,757 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-11-23 | 1,296 | $3.00 | 157,053 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-23 | 1,296 | $21.21 | 155,757 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non- Qualified Stock Option (right to buy) (2011 Plan) | Disposition | 2015-11-23 | 1,296 | $0.00 | 1,296 | $3.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,779 | 2023-02-20 | No | 4 | M | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.